-
EdU Flow Cytometry Assay Kits (Cy3): From Signal to Mechanis
2026-09-10
EdU Flow Cytometry Assay Kits (Cy3) provide denaturation-free DNA synthesis measurement for rigorous cell cycle analysis. This article explains how to use EdU data to test proliferation mechanisms inspired by recent miR-200c research in pancreatic cancer.
-
CFTRinh-172: Applied CFTR Inhibitor Workflows
2026-09-10
CFTRinh-172 provides rapid, selective suppression of CFTR-dependent chloride transport for epithelial transport, trafficking, and secretory-fluid assays. This guide connects practical dosing and solvent control with the latest SHC-1/CFTR surface-abundance findings, helping researchers distinguish channel number from channel activity.
-
Merimepodib (VX-497): A Guanine Nucleotide Stress Test
2026-09-09
Merimepodib (VX-497) is more than an IMPDH inhibitor: it is a mechanistic tool for testing how guanine nucleotide availability shapes viral replication, lymphocyte activation, and translational assay design. This article connects recent PEDV findings with practical controls for rigorous host-directed antiviral research.
-
Dabigatran: From Thrombin Biology to Translation
2026-09-09
Dabigatran is more than a direct thrombin inhibitor: it is a translational tool for connecting thrombin biology, assay design, and anticoagulation strategy. This article explains how to use Dabigatran and its active metabolite context to build more interpretable coagulation studies while avoiding common formulation, exposure, and renal-clearance pitfalls.
-
Tranexamic Acid for Reliable Fibrinolysis Assays
2026-09-08
Learn how Tranexamic Acid (SKU B1858) can improve control of plasmin-driven fibrinolysis, matrix stability, and neutrophil-adherence workflows without introducing DMSO or ethanol. This scenario-based guide connects assay design, dose optimization, data interpretation, and practical product selection to published evidence and documented product specifications.
-
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-09-08
The reference review explains how dabigatran etexilate addressed major limitations of vitamin K antagonists and injectable anticoagulants by delivering a rapidly acting, predictable, reversible oral direct thrombin inhibitor. Its discussion of prodrug activation, renal clearance, clinical efficacy, safety, and assay interpretation remains useful for designing translational coagulation studies while highlighting the limits of transferring clinical evidence directly to in vitro workflows.
-
Toremifene vs Tamoxifen in Advanced Breast Cancer
2026-09-07
This Cochrane review evaluated whether toremifene offers clinically meaningful efficacy or safety advantages over tamoxifen in advanced breast cancer. Across randomized comparisons, the evidence did not demonstrate a clear difference in tumor response, disease control, progression, or survival, while detailed adverse-event assessment remained important for treatment selection.
-
D-N-Acetylgalactosamine: Protocol & QC Guide
2026-09-07
D-N-Acetylgalactosamine (SKU B7904) provides a defined amino sugar for aqueous workflows involving glycoprotein composition, brain heteropolysaccharides analysis, and related glycosylation pathway studies. It is appropriate for water-based or validated DMSO-based procedures, but should not be selected for ethanol-dependent methods or long-term storage of prepared solutions.
-
Polybrene Workflows for Viral Gene Delivery
2026-09-05
Polybrene (Hexadimethrine Bromide) improves viral attachment and uptake while supporting difficult DNA-transfection workflows. This practical guide connects controlled Polybrene optimization with engineered p53Y220C assay models, without confusing a delivery reagent with the biology of mutant-p53 reactivation.
-
CDK9 inhibitor A3294: Practical Protocol Guide
2026-09-04
CDK9 inhibitor A3294 provides a selective tool for examining CDK9-dependent transcription elongation and P-TEFb-related HIV-1 propagation workflows while limiting interpretation from broad CDK inhibition. It is suited to controlled biochemical and cell-based studies, but not to pan-CDK experiments, general conclusions about cell cycle regulation, or long-term storage of prepared solutions.
-
Polybrene (Hexadimethrine Bromide): Use & Limits
2026-09-04
Polybrene, also called Hexadimethrine Bromide, is a cationic polymer used to improve viral gene delivery and selected transfection workflows. The 10 mg/mL formulation supports reproducible handling, but cell-specific toxicity testing and assay controls remain essential.
-
CCR7–Notch1 Crosstalk Drives Mammary Cancer Stemness
2026-09-03
Boyle et al. identify functional crosstalk between CCR7 and Notch1 in primary MMTV-PyMT mammary cancer cells, linking chemokine signaling to maintenance of a stem-like tumor-cell state. Their combination of CCR7 loss-of-function, pathway inhibition, molecular readouts, and cellular assays supports dual-axis investigation while also highlighting the limits of extrapolating cell-based findings to therapeutic efficacy.
-
Eldecalcitol, Endothelial Ferroptosis, and T2DOP
2026-09-03
A 2025 study identifies endothelial ferroptosis as a mechanistic contributor to type 2 diabetic osteoporosis and proposes an SOCE/O-GlcNAcylation pathway through which eldecalcitol may restore vascular–bone coupling. Its combined cell and mouse experiments connect redox injury, type H vessel dysfunction, and impaired osteogenesis, while highlighting pharmacological pathway validation as an important next step.
-
Sulforaphane Suppresses NLRP3 in Ulcerative Colitis
2026-09-02
The reference study integrates a dextran sodium sulfate mouse model with RAW264.7 cell experiments to show that Sulforaphane reduces oxidative stress and suppresses NLRP3 inflammasome activation during colitis. Its main practical contribution is a mechanistic link between reactive oxygen species and inflammatory signaling, while its findings remain preclinical and model-dependent.
-
Cell Counting Kit-8 Plus for Ferroptosis Studies
2026-09-02
Cell Counting Kit-8 Plus provides a fast, water-soluble WST-8 readout for connecting colorectal cancer cell survival with SLC11A1-associated ferroptosis resistance. This workflow emphasizes assay design, metabolic confounder controls, and orthogonal validation rather than treating absorbance as a direct cell count.